AKT1 and plasma cell myeloma: VPA has been shown to increase the expression of NKG2D ligands in myeloma cells via an ERK-dependent mechanism (21) and to increase the expression of MICA/B in pancreatic cancer cells via a PI3K/Akt signal pathway (22).